Advisors Preferred’s Elanco Animal Health ELAN Stock Holding History

Advisors Preferred’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-660	Closed	-$9.66K	–	197
2023 Q4	$9.66K	Sell	660 -71	-10%	-$804	﹤0.01%	211
2023 Q3	$8.01K	Sell	731 -242	-25%	-$2.81K	﹤0.01%	185
2023 Q2	$9.76K	Hold	973	–	–	﹤0.01%	161
2023 Q1	$9K	Buy	+973	New	+$11.5K	﹤0.01%	182

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Advisors Preferred's ELAN Position: Q1 2024 in Review

Advisors Preferred sold out of Elanco Animal Health (ELAN) in Q1 2024, closing a stake of 660 shares — an estimated $9.66K sold.

Advisors Preferred first reported a position in ELAN in Q1 2023 and held it in 4 quarters. The position peaked at $9.76K in Q2 2023. 374 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

Advisors Preferred reported no remaining Elanco Animal Health position as of Q1 2024 after selling out during the quarter.
Advisors Preferred sold 660 Elanco Animal Health shares in Q1 2024, an estimated $9.66K.
Advisors Preferred first reported a position in Elanco Animal Health in Q1 2023 and held it in 4 quarters.
Advisors Preferred's Elanco Animal Health position peaked at $9.76K in Q2 2023.
374 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Advisors Preferred's 13F filing for Q1 2024, filed 8 May 2024.